IHS Chemical Week

People & Business :: M&A

Pfizer's Zoetis animal health unit raises $2.24 billion in IPO

7:20 AM MST | February 1, 2013 | Natasha Alperowicz

Zoetis (Madison, NJ), the animal health unit owned by Pfizer, raised $2.24 billion in its previously announced initial public offering. Zoetis sold 86.1 million of its Class A common stock at $26/share, the company said on Thursday. Pfizer retains 100% of the outstanding Class B common stock of Zoetis and an 83% ownership in the company. The price values Zoetis at $13 billion.   The shares start trading today on the New York Stock Exchange. The IPO was led by J.P. Morgan Chase, Bank of America, and Morgan Stanley. Skadden (New York) is advising Pfizer...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa